Combined analysis of morphology and fluorescence in situ hybridization in follow-up of minimal residual disease in a child with Philadelphia-positive acute lymphoblastic leukemia
- 1 October 2002
- journal article
- case report
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 138 (1) , 64-68
- https://doi.org/10.1016/s0165-4608(02)00578-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridizationCancer Genetics and Cytogenetics, 2000
- Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2000
- Minimal Residual Disease in Hematologic DisordersArchives of Pathology & Laboratory Medicine, 1999
- Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopyGenes, Chromosomes and Cancer, 1999
- Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemiaBritish Journal of Haematology, 1998
- Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaThe Lancet, 1998
- Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1997
- Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemiaBritish Journal of Haematology, 1996